Uses and adverse effects of topical administration of atropine.
Smith
L G
LG
D000287:Administration, Topical; D001285:Atropine / Q000008:administration & dosage / Q000009:adverse effects* / Q000506:poisoning; D001463:Barbiturates / Q000627:therapeutic use; D006801:Humans; D047348:Hydrolyzable Tannins / Q000627:therapeutic use; D010830:Physostigmine / Q000627:therapeutic use
D001463:Barbiturates; D047348:Hydrolyzable Tannins; D001285:Atropine; D010830:Physostigmine